Log In
Print
BCIQ
Print
Print this Print this
 

Renvela, sevelamer carbonate

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionNext-generation version of Renagel, a non-absorbed phosphate binder
Molecular Target Phosphate
Mechanism of ActionPhosphate binder
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyperphosphatemia
Indication DetailsTreat hyperphosphatemia in patients receiving hemodialysis or peritoneal dialysis and in patients with chronic kidney disease (CKD) not on dialysis; Treat hyperphosphatemic patients with chronic kidney disease (CKD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today